CLOROX CO /DE/ — Director's Dealing 2022

Jun 10, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2022-06-01

Reporting Person: Ott Michael M (SVP - Chief Research & Dev Off)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3979.0000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$84.4500	2023-09-17	Common Stock (4440.0000)		Direct
Stock Option (Right to Buy)	$89.8200	2024-09-17	Common Stock (4790.0000)		Direct
Stock Option (Right to Buy)	$111.6000	2025-09-15	Common Stock (4860.0000)		Direct
Stock Option (Right to Buy)	$123.0900	2026-09-13	Common Stock (4710.0000)		Direct
Stock Option (Right to Buy)	$135.5700	2027-09-12	Common Stock (3620.0000)		Direct
Stock Option (Right to Buy)	$151.8500	2028-09-18	Common Stock (2490.0000)		Direct
Stock Option (Right to Buy)	$155.5400	2029-09-17	Common Stock (2815.0000)		Direct
Stock Option (Right to Buy)	$163.7700	2031-09-21	Common Stock (2244.0000)		Direct
Stock Option (Right to Buy)	$212.3800	2030-09-22	Common Stock (1619.0000)		Direct

Footnotes

F1: Option vested in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date.

F2: Option vests in 4 equal installments - 1/4 on each of the first, second and third anniversaries of the grant date and 1/4 on September 13, 2022.

F3: Option vests in 4 equal installments - 1/4 on each of the first and second anniversaries of the grant date and 1/4 on each of September 13, 2022 and 2023.

F4: Option vests in 4 equal installments - 1/4 on each of October 5, 2022, 2023, 2024, and 2025.

F5: Option vests in 4 equal installments - 1/4 on the first anniversary of the grant date and 1/4 on each of September 13, 2022, 2023, and 2024.